ENTITY

Roche Holding (ROG SE)

49
Analysis
Health Care • United States
Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system. Roche Holding serves customers worldwide.
more
bullish•FUCHS (Pref)
•17 Mar 2026 22:04

Liquid Universe of European Ordinary and Preferred Shares: March '26 Report

March saw convergence across European dual-class shares, with dispersion narrowing as liquidity returned. Structural outliers persist, while...

Share
bullish•Danieli
•17 Feb 2026 21:12

Liquid Universe of European Ordinary and Preferred Shares: February '26 Report

February brought mild widening in Europe’s dual-class spreads, but no systemic repricing of voting rights. Dispersion remains driven by structural...

Share
•19 Jan 2026 13:45

Liquid Universe of European Ordinary and Preferred Shares: January '26 Report

January confirmed dispersion without repricing in European dual-class stocks: liquidity and structure drove selective convergence, while a few...

Share
•14 Jan 2026 13:45

2025 in Review: Liquid Universe of European Ordinary and Preferred Shares

2025 saw dispersion without repricing in Europe’s dual-class stocks: a stable median hid sharp, liquidity-driven divergences, with convergence...

Share
•16 Dec 2025 21:04

Liquid Universe of European Ordinary and Preferred Shares: December'25 Report

December added technical noise, not thesis risk: median spreads were unchanged, convergence paused but intact, marginal voting premia erode, and...

Share
x